Status:

COMPLETED

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Multiple Myeloma

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The main objective of this study is to examine if absence of a satisfactory response on DCE-WB-MRI (see MR criteria of responders section) after completion of HDT followed by autologous stem-cell tran...

Detailed Description

Introduction Bone marrow angiogenesis is increased in multiple myeloma (MM) and is an important prognostic factor for survival. Newly diagnosed MM patients have higher microvessel density (MVD) than c...

Eligibility Criteria

Inclusion

  • Patient referred to one of the hematology departement associated with the research project, with confirmed multiple myeloma defined according to uniform international criteria.
  • Whatever stage classification according to Salmon and Durie with a life expectancy of more than 3 months.
  • Age under 70 years old (amendment n°5) and eligible for autologous stem cell transplantation.
  • Free and informed consent.

Exclusion

  • Patient unfit physically, mentally or legally to give informed consent.
  • Patient non affiliate with social security scheme
  • Patient with myeloma without measurable monoclonal immunoglobulin, including measurement of serum free light chains.
  • Patient with another malignancy excluding basal cell cancer.
  • Patient who could not undergo MRI (incompatible metallic foreign body, pacemaker, allergy to contrast, claustrophobia despite premedication, pregnancy, renal failure with creatinine clearance \<30 ml/min

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2019

Estimated Enrollment :

104 Patients enrolled

Trial Details

Trial ID

NCT01171430

Start Date

July 1 2010

End Date

February 1 2019

Last Update

November 20 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Henri Mondor Hospital

Créteil, France, 94010